Neurocrine Biosciences Stocks List

Recent Signals

Date Stock Signal Type
2021-03-03 NBIX Lower Bollinger Band Walk Weakness
2021-03-03 SPRB NR7 Range Contraction
2021-03-03 SPRB Narrow Range Bar Range Contraction
2021-03-03 SPRB Stochastic Reached Oversold Weakness
2021-03-03 SPRB MACD Bearish Signal Line Cross Bearish
Related Industries: Biotechnology

Neurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD).The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids.

More about Neurocrine Biosciences
Browse All Tags